Morbid Obesity
Conditions
Keywords
Morbid Obesity, Obesity, Weight Loss, Bariatric Surgery
Brief summary
The purpose of this registry is to monitor and evaluate the efficacy, as well as safety, of bariatric surgery performed at UMass Memorial Medical Center, including laparoscopic gastric bypass surgery and laparoscopic gastric banding, in the surgical treatment of morbid obesity and associated co-morbidities such as type 2 diabetes, sleep apnea and cardiovascular disease.
Detailed description
See brief Summary
Interventions
OTHERObservational Study
This is an Observational study
Sponsors
University of Massachusetts, Worcester
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Must be scheduled for Bariatric Surgery @ UMMMC
Exclusion criteria
* Not scheduled for Bariatric Surgery @ UMMMC
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Weight Loss after surgery | Preop, Postop, Six Months, and Annually | Baseline weight is recorded preoperatively. Time points after surgery when weight is recorded are two weeks, six weeks, 6 months, 1 year, 18 months, 2 years, then annually on the anniversary date of surgery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Resolution of Co-morbidities, such as Type 2 Diabetes, Sleep Apnea, Hypertension | Preop, Postop, Six Months, Annually | Preoperatively co-morbidities of morbid obesity are recorded as well as treatment (ie: medications, CPAP machine). Resolution of co-morbidities postoperatively is measured/recorded for example by blood tests, sleep study, as well as changes or discontinuation of medications &/or interventions. |
Countries
United States
Outcome results
None listed